Study Evaluating Tigecycline in Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA) - Related Studies

Study Evaluating Tigecycline in Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA)

This study has been completed.

Study NCT00079976. Last updated on October 9, 2007. Information provided by Wyeth

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Gram-Positive Bacterial Infections
		Staphylococcus Infections
		Vancomycin Resistance
		Methicillin Resistance

2	Additional conditions recognized in this trial
		Bacterial Infections
		Communicable Diseases
		Infection
		Staphylococcal Infections

3	Interventions listed in this trial
		Tigecycline

4	Additional drug interventions recognized in this trial
		Methicillin

5	More general drug interventions related to this trial
		Anti-Bacterial Agents
		Anti-Infective Agents
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		Wyeth